NIH #4R01NS076815-13
Endocannabinoids in neurodegenerative diseases
- Amount
- $704K
- Period
- 2012-06-15 → 2028-04-30
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine
7 total · 7 active
NIH #4R01NS076815-13
Awarded at UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
NIH #4R01AG081362-02
Awarded at UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
NIH #5R01CA273595-04
Awarded at UT SOUTHWESTERN MEDICAL CENTER
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Future Science OA · 2026-03-09
Oncogene · 2025-12-03 · 2 citations
Shaping Precision Medicine: The Journey of Sequencing Technologies Across Human Solid Tumors
Biomedicines · 2025-10-29 · 2 citations
Cell Cycle · 2025-10-22
Langmuir · 2025-10-15
AND-1 is a critical regulator of R-loop dynamics and a target to overcome endocrine resistance
Science Advances · 2025-08-06 · 1 citations
Gels · 2025-07-23 · 3 citations
Cancers · 2025-06-28 · 11 citations
LILRB4 exacerbates myocardial ischemia-reperfusion injury by promoting inflammation and pyroptosis
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025-06-21 · 3 citations
Human Molecular Genetics · 2025-05-08 · 3 citations
Cancer Research · 2025-04-21
Lubricants · 2025-02-25 · 3 citations
Carcinogenesis · 2025-02-01
Payoff Control in Multichannel Games: Influencing Opponent Learning Evolution
IEEE Transactions on Cybernetics · 2025-01-03 · 8 citations